Crohn’s Disease Drug Industry Research Report 2025
Description
Summary
According to APO Research, the global Crohn’s Disease Drug market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Crohn’s Disease Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Crohn’s Disease Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Crohn’s Disease Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Crohn’s Disease Drug include Janssen Biotech, Takeda Pharmaceuticals, Amgen, AbbVie and Tillotts Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Crohn’s Disease Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Crohn’s Disease Drug.
The report will help the Crohn’s Disease Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Crohn’s Disease Drug market size, estimations, and forecasts are provided in terms of sales volume (k tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Crohn’s Disease Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Crohn’s Disease Drug Segment by Company
Janssen Biotech
Takeda Pharmaceuticals
Amgen
AbbVie
Tillotts Pharma
Crohn’s Disease Drug Segment by Type
Aminosalicylates (5-ASA)
Antibiotics
Immunomodulators
Corticosteroids
Crohn’s Disease Drug Segment by Application
Pediatric Crohn'S Disease
Maintaining Remission (Prevention Of Flare-Ups)
Achieving Remission (The Absence Of Symptoms)
Crohn’s Disease Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Crohn’s Disease Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Crohn’s Disease Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Crohn’s Disease Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Crohn’s Disease Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Crohn’s Disease Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Crohn’s Disease Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
According to APO Research, the global Crohn’s Disease Drug market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Crohn’s Disease Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Crohn’s Disease Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Crohn’s Disease Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Crohn’s Disease Drug include Janssen Biotech, Takeda Pharmaceuticals, Amgen, AbbVie and Tillotts Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Crohn’s Disease Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Crohn’s Disease Drug.
The report will help the Crohn’s Disease Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Crohn’s Disease Drug market size, estimations, and forecasts are provided in terms of sales volume (k tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Crohn’s Disease Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Crohn’s Disease Drug Segment by Company
Janssen Biotech
Takeda Pharmaceuticals
Amgen
AbbVie
Tillotts Pharma
Crohn’s Disease Drug Segment by Type
Aminosalicylates (5-ASA)
Antibiotics
Immunomodulators
Corticosteroids
Crohn’s Disease Drug Segment by Application
Pediatric Crohn'S Disease
Maintaining Remission (Prevention Of Flare-Ups)
Achieving Remission (The Absence Of Symptoms)
Crohn’s Disease Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Crohn’s Disease Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Crohn’s Disease Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Crohn’s Disease Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Crohn’s Disease Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Crohn’s Disease Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Crohn’s Disease Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Table of Contents
119 Pages
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Crohn’s Disease Drug Market Size (2020-2031)
- 2.2.2 Global Crohn’s Disease Drug Sales (2020-2031)
- 2.2.3 Global Crohn’s Disease Drug Market Average Price (2020-2031)
- 2.3 Crohn’s Disease Drug by Type
- 2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
- 2.3.2 Aminosalicylates (5-ASA)
- 2.3.3 Antibiotics
- 2.3.4 Immunomodulators
- 2.3.5 Corticosteroids
- 2.4 Crohn’s Disease Drug by Application
- 2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
- 2.4.2 Pediatric Crohn'S Disease
- 2.4.3 Maintaining Remission (Prevention Of Flare-Ups)
- 2.4.4 Achieving Remission (The Absence Of Symptoms)
- 3 Market Competitive Landscape by Manufacturers
- 3.1 Global Crohn’s Disease Drug Market Competitive Situation by Manufacturers (2020 Versus 2024)
- 3.2 Global Crohn’s Disease Drug Sales (k tons) of Manufacturers (2020-2025)
- 3.3 Global Crohn’s Disease Drug Revenue of Manufacturers (2020-2025)
- 3.4 Global Crohn’s Disease Drug Average Price by Manufacturers (2020-2025)
- 3.5 Global Crohn’s Disease Drug Industry Ranking, 2023 VS 2024 VS 2025
- 3.6 Global Manufacturers of Crohn’s Disease Drug, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Crohn’s Disease Drug, Product Type & Application
- 3.8 Global Manufacturers of Crohn’s Disease Drug, Established Date
- 3.9 Global Crohn’s Disease Drug Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
- 4 Manufacturers Profiled
- 4.1 Janssen Biotech
- 4.1.1 Janssen Biotech Company Information
- 4.1.2 Janssen Biotech Business Overview
- 4.1.3 Janssen Biotech Crohn’s Disease Drug Sales, Revenue and Gross Margin (2020-2025)
- 4.1.4 Janssen Biotech Crohn’s Disease Drug Product Portfolio
- 4.1.5 Janssen Biotech Recent Developments
- 4.2 Takeda Pharmaceuticals
- 4.2.1 Takeda Pharmaceuticals Company Information
- 4.2.2 Takeda Pharmaceuticals Business Overview
- 4.2.3 Takeda Pharmaceuticals Crohn’s Disease Drug Sales, Revenue and Gross Margin (2020-2025)
- 4.2.4 Takeda Pharmaceuticals Crohn’s Disease Drug Product Portfolio
- 4.2.5 Takeda Pharmaceuticals Recent Developments
- 4.3 Amgen
- 4.3.1 Amgen Company Information
- 4.3.2 Amgen Business Overview
- 4.3.3 Amgen Crohn’s Disease Drug Sales, Revenue and Gross Margin (2020-2025)
- 4.3.4 Amgen Crohn’s Disease Drug Product Portfolio
- 4.3.5 Amgen Recent Developments
- 4.4 AbbVie
- 4.4.1 AbbVie Company Information
- 4.4.2 AbbVie Business Overview
- 4.4.3 AbbVie Crohn’s Disease Drug Sales, Revenue and Gross Margin (2020-2025)
- 4.4.4 AbbVie Crohn’s Disease Drug Product Portfolio
- 4.4.5 AbbVie Recent Developments
- 4.5 Tillotts Pharma
- 4.5.1 Tillotts Pharma Company Information
- 4.5.2 Tillotts Pharma Business Overview
- 4.5.3 Tillotts Pharma Crohn’s Disease Drug Sales, Revenue and Gross Margin (2020-2025)
- 4.5.4 Tillotts Pharma Crohn’s Disease Drug Product Portfolio
- 4.5.5 Tillotts Pharma Recent Developments
- 5 Global Crohn’s Disease Drug Market Scenario by Region
- 5.1 Global Crohn’s Disease Drug Market Size by Region: 2020 VS 2024 VS 2031
- 5.2 Global Crohn’s Disease Drug Sales by Region: 2020-2031
- 5.2.1 Global Crohn’s Disease Drug Sales by Region: 2020-2025
- 5.2.2 Global Crohn’s Disease Drug Sales by Region: 2026-2031
- 5.3 Global Crohn’s Disease Drug Revenue by Region: 2020-2031
- 5.3.1 Global Crohn’s Disease Drug Revenue by Region: 2020-2025
- 5.3.2 Global Crohn’s Disease Drug Revenue by Region: 2026-2031
- 5.4 North America Crohn’s Disease Drug Market Facts & Figures by Country
- 5.4.1 North America Crohn’s Disease Drug Market Size by Country: 2020 VS 2024 VS 2031
- 5.4.2 North America Crohn’s Disease Drug Sales by Country (2020-2031)
- 5.4.3 North America Crohn’s Disease Drug Revenue by Country (2020-2031)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Crohn’s Disease Drug Market Facts & Figures by Country
- 5.5.1 Europe Crohn’s Disease Drug Market Size by Country: 2020 VS 2024 VS 2031
- 5.5.2 Europe Crohn’s Disease Drug Sales by Country (2020-2031)
- 5.5.3 Europe Crohn’s Disease Drug Revenue by Country (2020-2031)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Crohn’s Disease Drug Market Facts & Figures by Country
- 5.6.1 Asia Pacific Crohn’s Disease Drug Market Size by Country: 2020 VS 2024 VS 2031
- 5.6.2 Asia Pacific Crohn’s Disease Drug Sales by Country (2020-2031)
- 5.6.3 Asia Pacific Crohn’s Disease Drug Revenue by Country (2020-2031)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Crohn’s Disease Drug Market Facts & Figures by Country
- 5.7.1 South America Crohn’s Disease Drug Market Size by Country: 2020 VS 2024 VS 2031
- 5.7.2 South America Crohn’s Disease Drug Sales by Country (2020-2031)
- 5.7.3 South America Crohn’s Disease Drug Revenue by Country (2020-2031)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Crohn’s Disease Drug Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Crohn’s Disease Drug Market Size by Country: 2020 VS 2024 VS 2031
- 5.8.2 Middle East and Africa Crohn’s Disease Drug Sales by Country (2020-2031)
- 5.8.3 Middle East and Africa Crohn’s Disease Drug Revenue by Country (2020-2031)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
- 6 Segment by Type
- 6.1 Global Crohn’s Disease Drug Sales by Type (2020-2031)
- 6.1.1 Global Crohn’s Disease Drug Sales by Type (2020-2031) & (k tons)
- 6.1.2 Global Crohn’s Disease Drug Sales Market Share by Type (2020-2031)
- 6.2 Global Crohn’s Disease Drug Revenue by Type (2020-2031)
- 6.2.1 Global Crohn’s Disease Drug Sales by Type (2020-2031) & (US$ Million)
- 6.2.2 Global Crohn’s Disease Drug Revenue Market Share by Type (2020-2031)
- 6.3 Global Crohn’s Disease Drug Price by Type (2020-2031)
- 7 Segment by Application
- 7.1 Global Crohn’s Disease Drug Sales by Application (2020-2031)
- 7.1.1 Global Crohn’s Disease Drug Sales by Application (2020-2031) & (k tons)
- 7.1.2 Global Crohn’s Disease Drug Sales Market Share by Application (2020-2031)
- 7.2 Global Crohn’s Disease Drug Revenue by Application (2020-2031)
- 7.2.1 Global Crohn’s Disease Drug Sales by Application (2020-2031) & (US$ Million)
- 7.2.2 Global Crohn’s Disease Drug Revenue Market Share by Application (2020-2031)
- 7.3 Global Crohn’s Disease Drug Price by Application (2020-2031)
- 8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Crohn’s Disease Drug Value Chain Analysis
- 8.1.1 Crohn’s Disease Drug Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Crohn’s Disease Drug Production Mode & Process
- 8.2 Crohn’s Disease Drug Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Crohn’s Disease Drug Distributors
- 8.2.3 Crohn’s Disease Drug Customers
- 9 Global Crohn’s Disease Drug Analyzing Market Dynamics
- 9.1 Crohn’s Disease Drug Industry Trends
- 9.2 Crohn’s Disease Drug Industry Drivers
- 9.3 Crohn’s Disease Drug Industry Opportunities and Challenges
- 9.4 Crohn’s Disease Drug Industry Restraints
- 10 Report Conclusion
- 11 Disclaimer
- List of Tables
- Table 1. Secondary Sources
- Table 2. Primary Sources
- Table 3. Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
- Table 4. Market Value Comparison by Application (2020 VS 2024 VS 2031) & (US$ Million)
- Table 5. Global Crohn’s Disease Drug Volume and Revenue Market Size and CAGR of Manufacturers (2020 Versus 2024)
- Table 6. Global Crohn’s Disease Drug Sales (k tons) of Manufacturers (2020-2025)
- Table 7. Global Crohn’s Disease Drug Sales Market Share by Manufacturers (2020-2025)
- Table 8. Global Crohn’s Disease Drug Revenue of Manufacturers (2020-2025)
- Table 9. Global Crohn’s Disease Drug Revenue Share by Manufacturers (2020-2025)
- Table 10. Global Market Crohn’s Disease Drug Average Price (US$/ton) of Manufacturers (2020-2025)
- Table 11. Global Crohn’s Disease Drug Industry Ranking, 2023 VS 2024 VS 2025
- Table 12. Global Manufacturers of Crohn’s Disease Drug, Manufacturing Sites & Headquarters
- Table 13. Global Manufacturers of Crohn’s Disease Drug, Product Type & Application
- Table 14. Global Crohn’s Disease Drug Manufacturers Established Date
- Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
- Table 16. Global Crohn’s Disease Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2024)
- Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
- Table 18. Janssen Biotech Company Information
- Table 19. Janssen Biotech Business Overview
- Table 20. Janssen Biotech Crohn’s Disease Drug Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2020-2025)
- Table 21. Janssen Biotech Crohn’s Disease Drug Product Portfolio
- Table 22. Janssen Biotech Recent Developments
- Table 23. Takeda Pharmaceuticals Company Information
- Table 24. Takeda Pharmaceuticals Business Overview
- Table 25. Takeda Pharmaceuticals Crohn’s Disease Drug Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2020-2025)
- Table 26. Takeda Pharmaceuticals Crohn’s Disease Drug Product Portfolio
- Table 27. Takeda Pharmaceuticals Recent Developments
- Table 28. Amgen Company Information
- Table 29. Amgen Business Overview
- Table 30. Amgen Crohn’s Disease Drug Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2020-2025)
- Table 31. Amgen Crohn’s Disease Drug Product Portfolio
- Table 32. Amgen Recent Developments
- Table 33. AbbVie Company Information
- Table 34. AbbVie Business Overview
- Table 35. AbbVie Crohn’s Disease Drug Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2020-2025)
- Table 36. AbbVie Crohn’s Disease Drug Product Portfolio
- Table 37. AbbVie Recent Developments
- Table 38. Tillotts Pharma Company Information
- Table 39. Tillotts Pharma Business Overview
- Table 40. Tillotts Pharma Crohn’s Disease Drug Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2020-2025)
- Table 41. Tillotts Pharma Crohn’s Disease Drug Product Portfolio
- Table 42. Tillotts Pharma Recent Developments
- Table 43. Global Crohn’s Disease Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
- Table 44. Global Crohn’s Disease Drug Sales by Region (2020-2025) & (k tons)
- Table 45. Global Crohn’s Disease Drug Sales Market Share by Region (2020-2025)
- Table 46. Global Crohn’s Disease Drug Sales by Region (2026-2031) & (k tons)
- Table 47. Global Crohn’s Disease Drug Sales Market Share by Region (2026-2031)
- Table 48. Global Crohn’s Disease Drug Revenue by Region (2020-2025) & (US$ Million)
- Table 49. Global Crohn’s Disease Drug Revenue Market Share by Region (2020-2025)
- Table 50. Global Crohn’s Disease Drug Revenue by Region (2026-2031) & (US$ Million)
- Table 51. Global Crohn’s Disease Drug Revenue Market Share by Region (2026-2031)
- Table 52. North America Crohn’s Disease Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 53. North America Crohn’s Disease Drug Sales by Country (2020-2025) & (k tons)
- Table 54. North America Crohn’s Disease Drug Sales by Country (2026-2031) & (k tons)
- Table 55. North America Crohn’s Disease Drug Revenue by Country (2020-2025) & (US$ Million)
- Table 56. North America Crohn’s Disease Drug Revenue by Country (2026-2031) & (US$ Million)
- Table 57. Europe Crohn’s Disease Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 58. Europe Crohn’s Disease Drug Sales by Country (2020-2025) & (k tons)
- Table 59. Europe Crohn’s Disease Drug Sales by Country (2026-2031) & (k tons)
- Table 60. Europe Crohn’s Disease Drug Revenue by Country (2020-2025) & (US$ Million)
- Table 61. Europe Crohn’s Disease Drug Revenue by Country (2026-2031) & (US$ Million)
- Table 62. Asia Pacific Crohn’s Disease Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 63. Asia Pacific Crohn’s Disease Drug Sales by Country (2020-2025) & (k tons)
- Table 64. Asia Pacific Crohn’s Disease Drug Sales by Country (2026-2031) & (k tons)
- Table 65. Asia Pacific Crohn’s Disease Drug Revenue by Country (2020-2025) & (US$ Million)
- Table 66. Asia Pacific Crohn’s Disease Drug Revenue by Country (2026-2031) & (US$ Million)
- Table 67. South America Crohn’s Disease Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 68. South America Crohn’s Disease Drug Sales by Country (2020-2025) & (k tons)
- Table 69. South America Crohn’s Disease Drug Sales by Country (2026-2031) & (k tons)
- Table 70. South America Crohn’s Disease Drug Revenue by Country (2020-2025) & (US$ Million)
- Table 71. South America Crohn’s Disease Drug Revenue by Country (2026-2031) & (US$ Million)
- Table 72. Middle East and Africa Crohn’s Disease Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 73. Middle East and Africa Crohn’s Disease Drug Sales by Country (2020-2025) & (k tons)
- Table 74. Middle East and Africa Crohn’s Disease Drug Sales by Country (2026-2031) & (k tons)
- Table 75. Middle East and Africa Crohn’s Disease Drug Revenue by Country (2020-2025) & (US$ Million)
- Table 76. Middle East and Africa Crohn’s Disease Drug Revenue by Country (2026-2031) & (US$ Million)
- Table 77. Global Crohn’s Disease Drug Sales by Type (2020-2025) & (k tons)
- Table 78. Global Crohn’s Disease Drug Sales by Type (2026-2031) & (k tons)
- Table 79. Global Crohn’s Disease Drug Sales Market Share by Type (2020-2025)
- Table 80. Global Crohn’s Disease Drug Sales Market Share by Type (2026-2031)
- Table 81. Global Crohn’s Disease Drug Revenue by Type (2020-2025) & (US$ Million)
- Table 82. Global Crohn’s Disease Drug Revenue by Type (2026-2031) & (US$ Million)
- Table 83. Global Crohn’s Disease Drug Revenue Market Share by Type (2020-2025)
- Table 84. Global Crohn’s Disease Drug Revenue Market Share by Type (2026-2031)
- Table 85. Global Crohn’s Disease Drug Price by Type (2020-2025) & (US$/ton)
- Table 86. Global Crohn’s Disease Drug Price by Type (2026-2031) & (US$/ton)
- Table 87. Global Crohn’s Disease Drug Sales by Application (2020-2025) & (k tons)
- Table 88. Global Crohn’s Disease Drug Sales by Application (2026-2031) & (k tons)
- Table 89. Global Crohn’s Disease Drug Sales Market Share by Application (2020-2025)
- Table 90. Global Crohn’s Disease Drug Sales Market Share by Application (2026-2031)
- Table 91. Global Crohn’s Disease Drug Revenue by Application (2020-2025) & (US$ Million)
- Table 92. Global Crohn’s Disease Drug Revenue by Application (2026-2031) & (US$ Million)
- Table 93. Global Crohn’s Disease Drug Revenue Market Share by Application (2020-2025)
- Table 94. Global Crohn’s Disease Drug Revenue Market Share by Application (2026-2031)
- Table 95. Global Crohn’s Disease Drug Price by Application (2020-2025) & (US$/ton)
- Table 96. Global Crohn’s Disease Drug Price by Application (2026-2031) & (US$/ton)
- Table 97. Key Raw Materials
- Table 98. Raw Materials Key Suppliers
- Table 99. Crohn’s Disease Drug Distributors List
- Table 100. Crohn’s Disease Drug Customers List
- Table 101. Crohn’s Disease Drug Industry Trends
- Table 102. Crohn’s Disease Drug Industry Drivers
- Table 103. Crohn’s Disease Drug Industry Restraints
- Table 104. Authors List of This Report
- List of Figures
- Figure 1. Research Methodology
- Figure 2. Research Process
- Figure 3. Key Executives Interviewed
- Figure 4. Crohn’s Disease Drug Product Image
- Figure 5. Global Crohn’s Disease Drug Revenue (US$ Million), 2020 VS 2024 VS 2031
- Figure 6. Global Crohn’s Disease Drug Market Size (2020-2031) & (US$ Million)
- Figure 7. Global Crohn’s Disease Drug Sales (2020-2031) & (k tons)
- Figure 8. Global Crohn’s Disease Drug Average Price (US$/ton) & (2020-2031)
- Figure 9. Aminosalicylates (5-ASA) Product Image
- Figure 10. Antibiotics Product Image
- Figure 11. Immunomodulators Product Image
- Figure 12. Corticosteroids Product Image
- Figure 13. Pediatric Crohn'S Disease Product Image
- Figure 14. Maintaining Remission (Prevention Of Flare-Ups) Product Image
- Figure 15. Achieving Remission (The Absence Of Symptoms) Product Image
- Figure 16. Global Crohn’s Disease Drug Revenue Share by Manufacturers in 2024
- Figure 17. Global Manufacturers of Crohn’s Disease Drug, Manufacturing Sites & Headquarters
- Figure 18. Global Top 5 and 10 Crohn’s Disease Drug Players Market Share by Revenue in 2024
- Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
- Figure 20. Global Crohn’s Disease Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
- Figure 21. Global Crohn’s Disease Drug Sales by Region in 2024
- Figure 22. Global Crohn’s Disease Drug Revenue by Region in 2024
- Figure 23. North America Crohn’s Disease Drug Market Size by Country in 2024
- Figure 24. North America Crohn’s Disease Drug Sales Market Share by Country (2020-2031)
- Figure 25. North America Crohn’s Disease Drug Revenue Market Share by Country (2020-2031)
- Figure 26. United States Crohn’s Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 27. Canada Crohn’s Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 28. Europe Crohn’s Disease Drug Market Size by Country in 2024
- Figure 29. Europe Crohn’s Disease Drug Sales Market Share by Country (2020-2031)
- Figure 30. Europe Crohn’s Disease Drug Revenue Market Share by Country (2020-2031)
- Figure 31. Germany Crohn’s Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 32. France Crohn’s Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 33. U.K. Crohn’s Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 34. Italy Crohn’s Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 35. Netherlands Crohn’s Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 36. Nordic Countries Crohn’s Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 37. Asia Pacific Crohn’s Disease Drug Market Size by Country in 2024
- Figure 38. Asia Pacific Crohn’s Disease Drug Sales Market Share by Country (2020-2031)
- Figure 39. Asia Pacific Crohn’s Disease Drug Revenue Market Share by Country (2020-2031)
- Figure 40. China Crohn’s Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 41. Japan Crohn’s Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 42. South Korea Crohn’s Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 43. India Crohn’s Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 44. Australia Crohn’s Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 45. China Taiwan Crohn’s Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 46. Southeast Asia Crohn’s Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 47. Southeast Asia Crohn’s Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 48. South America Crohn’s Disease Drug Market Size by Country in 2024
- Figure 49. South America Crohn’s Disease Drug Sales Market Share by Country (2020-2031)
- Figure 50. South America Crohn’s Disease Drug Revenue Market Share by Country (2020-2031)
- Figure 51. Mexico Crohn’s Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 52. Brazil Crohn’s Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 53. Argentina Crohn’s Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 54. Middle East and Africa Crohn’s Disease Drug Market Size by Country in 2024
- Figure 55. Middle East and Africa Crohn’s Disease Drug Sales Market Share by Country (2020-2031)
- Figure 56. Middle East and Africa Crohn’s Disease Drug Revenue Market Share by Country (2020-2031)
- Figure 57. Turkey Crohn’s Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 58. Saudi Arabia Crohn’s Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 59. UAE Crohn’s Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 60. Global Crohn’s Disease Drug Sales Market Share by Type (2020-2031)
- Figure 61. Global Crohn’s Disease Drug Revenue Market Share by Type (2020-2031)
- Figure 62. Global Crohn’s Disease Drug Price (US$/ton) by Type (2020-2031)
- Figure 63. Global Crohn’s Disease Drug Sales Market Share by Application (2020-2031)
- Figure 64. Global Crohn’s Disease Drug Revenue Market Share by Application (2020-2031)
- Figure 65. Global Crohn’s Disease Drug Price (US$/ton) by Application (2020-2031)
- Figure 66. Crohn’s Disease Drug Value Chain
- Figure 67. Crohn’s Disease Drug Production Mode & Process
- Figure 68. Direct Comparison with Distribution Share
- Figure 69. Distributors Profiles
- Figure 70. Crohn’s Disease Drug Industry Opportunities and Challenges
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
